Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Closed-loop systems: Where are we now?

Thursday 21st February, 16:40-18:00

Outcomes of the Medtronic 670G in diabetes clinics in the USA – Bruce Bode

Progress on using Cambridge Closed-Loop algorithm – Roman Hovorka

Harvard's experience with closed-loop – Eyal Dassau

Virginia's experience with closed-loop – Sue Brown

Update from the FLAIR study – Tadej Battelino

Pramlintide in the artificial pancreas – Ahmad Haidar

Value vs. affordability of diabetes technology – John Pickup

print
PRINT
Image Credits